Zydus Lifesciences Limited has informed the Exchange regarding a press release dated Jun 09, 2023, titled "Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in Non-Alcoholic Fatty Liver Disease (NAFLD) patients with comorbidities".